Manli Cui

Department of Gastroenterology, First Affiliated Hospital of Xian Medical University

Affiliated withFirst Affiliated Hospital of Xian Medical University

Research Area

Biography

Manli Cui has not added Biography.
If you are Manli Cui and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer. Journal of cellular biochemistry\| PubMed ID: 31464068	2019
Function, Significance, and Regulation of Rap1b in Malignancy. Critical reviews in eukaryotic gene expression\| PubMed ID: 31679270	2019
Circular RNAs and esophageal cancer. Cancer cell international\| PubMed ID: 32774156	2020
[Positive lymph node ratio ≥0.16 is an independent risk factor affecting the prognosis of patients with esophageal cancer]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University\| PubMed ID: 32895212	2020
Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer. Cancer cell international\| PubMed ID: 33596916	2021
Recent advances of mA methylation modification in esophageal squamous cell carcinoma. Cancer cell international\| PubMed ID: 34376206	2021
Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment. Journal of gastrointestinal oncology\| PubMed ID: 34532084	2021
Editorial: Drug Delivery System Based on Nanoparticles for Inflammation and Cancer Therapy. Frontiers in molecular biosciences\| PubMed ID: 35720118	2022
MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer. Cancer gene therapy\| PubMed ID: 36599972	2023
First-line treatment options for advanced gastric/gastroesophageal junction cancer patients with PD-L1-positive: a systematic review and meta-analysis. Annals of medicine and surgery (2012)\| PubMed ID: 37363517	2023
Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis. ACS applied materials & interfaces\| PubMed ID: 37463480	2023
Role of epigenetic modifications mediated by vitamins and trace elements in inflammatory bowel disease. Epigenomics\| PubMed ID: 37694343	2023
The Relationship Between Psychological Conditions and Gastrointestinal Symptoms of Medical Students During the COVID-19 Pandemic. Neuropsychiatric disease and treatment\| PubMed ID: 38751379	2024
Interaction of Exosomal MicroRNA and Oxidative Stress in the Pathogenesis of Colitis-Associated Cancer. Frontiers in bioscience (Landmark edition)\| PubMed ID: 39206897	2024
Nanomedicine: The new trend and future of precision medicine for inflammatory bowel disease. Chinese medical journal\| PubMed ID: 39679456	2024
SPAG5 is a potential therapeutic target affecting proliferation, apoptosis, and invasion of esophageal cancer cells. European journal of medical research\| PubMed ID: 39696708	2024
Oral administration of Momordica charantia-derived extracellular vesicles alleviates ulcerative colitis through comprehensive renovation of the intestinal microenvironment. Journal of nanobiotechnology\| PubMed ID: 40170075	2025
Endoscopic Clot Removal Is an Effective Method for Treating Massive Ruptured Esophageal Hematoma: A Case Report. Case reports in gastroenterology\| PubMed ID: 40196421	2025
New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites. Computational and structural biotechnology journal\| PubMed ID: 40470314	2025
Association between infection of Helicobacter pylori and the risk of reflux oesophagitis occurrence or recurrence: a systematic review and meta-analysis. eGastroenterology\| PubMed ID: 40589426	2025
Medicinal Plant-Derived Carbon Dots Nanozymes Ameliorate Ulcerative Colitis via Anti-inflammatory, Antioxidant, and Gut Barrier-Protective Effects. ACS applied materials & interfaces\| PubMed ID: 40611517	2025
in esophageal carcinogenesis: Potential culprit or forceful defender? Virulence\| PubMed ID: 41178453	2025
Lactate and gastric cancer immunotherapy from regulatory mechanisms to therapeutic strategies: a critical review. European journal of medical research\| PubMed ID: 41239494	2025
The gut microbiota dysbiosis in geriatric multimorbidity: Pharmacotherapeutic implications, pathophysiological mechanisms, and precision modulation strategies. Ageing research reviews\| PubMed ID: 41539609	2026
Regulation of SLC7A11 by METTL3 induces cisplatin resistance in esophageal cancer. International journal of biological macromolecules\| PubMed ID: 41967541	2026